Leonid Timashev
Stock Analyst at RBC Capital
(4.58)
# 170
Out of 5,090 analysts
131
Total ratings
58.62%
Success rate
20.51%
Average return
Main Sectors:
Stocks Rated by Leonid Timashev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DSGN Design Therapeutics | Upgrades: Outperform | $6 → $13 | $9.77 | +33.06% | 10 | Nov 20, 2025 | |
| ONC BeOne Medicines AG | Maintains: Outperform | $395 → $408 | $322.90 | +26.35% | 5 | Nov 18, 2025 | |
| CGON CG Oncology | Maintains: Outperform | $53 → $61 | $43.30 | +40.88% | 2 | Nov 17, 2025 | |
| LEGN Legend Biotech | Maintains: Outperform | $75 → $74 | $28.13 | +163.06% | 14 | Nov 13, 2025 | |
| JSPR Jasper Therapeutics | Maintains: Sector Perform | $5 → $4 | $1.71 | +133.92% | 1 | Nov 11, 2025 | |
| CYTK Cytokinetics | Maintains: Outperform | $82 → $87 | $65.67 | +32.48% | 4 | Nov 11, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Outperform | $49 → $50 | $23.59 | +111.95% | 15 | Nov 7, 2025 | |
| XNCR Xencor | Maintains: Outperform | $18 → $19 | $17.30 | +9.83% | 3 | Nov 6, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Outperform | $39 → $44 | $35.26 | +24.79% | 8 | Nov 6, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $151 → $155 | $169.70 | -8.66% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $19 → $9 | $9.55 | -5.76% | 13 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $8 | $8.55 | -6.43% | 3 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $189 → $198 | $149.22 | +32.69% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $77 | $79.64 | -3.31% | 1 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $139 → $215 | $204.00 | +5.39% | 6 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $27 → $11 | $7.07 | +55.59% | 2 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $47 | $29.52 | +59.21% | 5 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $45 | $44.36 | +1.44% | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $21 → $22 | $10.56 | +108.33% | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 → $41 | $35.87 | +14.30% | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $13 | $10.36 | +25.48% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $5 | $3.29 | +51.98% | 1 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $16 | $2.40 | +566.67% | 1 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $8 | $4.22 | +89.57% | 6 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.25 | +140.00% | 1 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $102.52 | -31.72% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $18 | $5.82 | +209.28% | 4 | Jan 15, 2025 |
Design Therapeutics
Nov 20, 2025
Upgrades: Outperform
Price Target: $6 → $13
Current: $9.77
Upside: +33.06%
BeOne Medicines AG
Nov 18, 2025
Maintains: Outperform
Price Target: $395 → $408
Current: $322.90
Upside: +26.35%
CG Oncology
Nov 17, 2025
Maintains: Outperform
Price Target: $53 → $61
Current: $43.30
Upside: +40.88%
Legend Biotech
Nov 13, 2025
Maintains: Outperform
Price Target: $75 → $74
Current: $28.13
Upside: +163.06%
Jasper Therapeutics
Nov 11, 2025
Maintains: Sector Perform
Price Target: $5 → $4
Current: $1.71
Upside: +133.92%
Cytokinetics
Nov 11, 2025
Maintains: Outperform
Price Target: $82 → $87
Current: $65.67
Upside: +32.48%
Edgewise Therapeutics
Nov 7, 2025
Maintains: Outperform
Price Target: $49 → $50
Current: $23.59
Upside: +111.95%
Xencor
Nov 6, 2025
Maintains: Outperform
Price Target: $18 → $19
Current: $17.30
Upside: +9.83%
NewAmsterdam Pharma Company
Nov 6, 2025
Maintains: Outperform
Price Target: $39 → $44
Current: $35.26
Upside: +24.79%
Jazz Pharmaceuticals
Nov 6, 2025
Maintains: Outperform
Price Target: $151 → $155
Current: $169.70
Upside: -8.66%
Nov 6, 2025
Maintains: Sector Perform
Price Target: $19 → $9
Current: $9.55
Upside: -5.76%
Nov 4, 2025
Maintains: Outperform
Price Target: $7 → $8
Current: $8.55
Upside: -6.43%
Nov 4, 2025
Maintains: Outperform
Price Target: $189 → $198
Current: $149.22
Upside: +32.69%
Nov 3, 2025
Initiates: Outperform
Price Target: $77
Current: $79.64
Upside: -3.31%
Oct 31, 2025
Maintains: Outperform
Price Target: $139 → $215
Current: $204.00
Upside: +5.39%
Oct 31, 2025
Downgrades: Sector Perform
Price Target: $27 → $11
Current: $7.07
Upside: +55.59%
Oct 23, 2025
Maintains: Outperform
Price Target: $45 → $47
Current: $29.52
Upside: +59.21%
Oct 21, 2025
Reiterates: Sector Perform
Price Target: $45
Current: $44.36
Upside: +1.44%
Oct 21, 2025
Maintains: Outperform
Price Target: $21 → $22
Current: $10.56
Upside: +108.33%
Oct 21, 2025
Maintains: Outperform
Price Target: $38 → $41
Current: $35.87
Upside: +14.30%
Aug 8, 2025
Maintains: Outperform
Price Target: $12 → $13
Current: $10.36
Upside: +25.48%
Jun 20, 2025
Maintains: Outperform
Price Target: $8 → $5
Current: $3.29
Upside: +51.98%
Jun 3, 2025
Maintains: Outperform
Price Target: $15 → $16
Current: $2.40
Upside: +566.67%
Mar 19, 2025
Reiterates: Outperform
Price Target: $8
Current: $4.22
Upside: +89.57%
Mar 19, 2025
Maintains: Buy
Price Target: $3
Current: $1.25
Upside: +140.00%
Jan 23, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $102.52
Upside: -31.72%
Jan 15, 2025
Reiterates: Outperform
Price Target: $18
Current: $5.82
Upside: +209.28%